Osuna-Gómez, R.; Arqueros, C.; Galano, C.; Mulet, M.; Zamora, C.; Barnadas, A.; Vidal, S.
Effector Mechanisms of CD8+ HLA-DR+ T Cells in Breast Cancer Patients Who Respond to Neoadjuvant Chemotherapy. Cancers 2021, 13, 6167.
https://doi.org/10.3390/cancers13246167
AMA Style
Osuna-Gómez R, Arqueros C, Galano C, Mulet M, Zamora C, Barnadas A, Vidal S.
Effector Mechanisms of CD8+ HLA-DR+ T Cells in Breast Cancer Patients Who Respond to Neoadjuvant Chemotherapy. Cancers. 2021; 13(24):6167.
https://doi.org/10.3390/cancers13246167
Chicago/Turabian Style
Osuna-Gómez, Rubén, Cristina Arqueros, Carla Galano, Maria Mulet, Carlos Zamora, Agustà Barnadas, and Silvia Vidal.
2021. "Effector Mechanisms of CD8+ HLA-DR+ T Cells in Breast Cancer Patients Who Respond to Neoadjuvant Chemotherapy" Cancers 13, no. 24: 6167.
https://doi.org/10.3390/cancers13246167
APA Style
Osuna-Gómez, R., Arqueros, C., Galano, C., Mulet, M., Zamora, C., Barnadas, A., & Vidal, S.
(2021). Effector Mechanisms of CD8+ HLA-DR+ T Cells in Breast Cancer Patients Who Respond to Neoadjuvant Chemotherapy. Cancers, 13(24), 6167.
https://doi.org/10.3390/cancers13246167